High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: A population-based cross-sectional study

British Journal of General Practice

Volumn 64, Issue 621, 2014, Pages

  Koffeman, Aafke R ^a   Valkhoff, Vera E ^a   Çelik, Sevde ^a   'T Jong, Geert W ^b,c   Sturkenboom, Miriam Cjm ^a   Bindels, Patrick J E ^a   Van Der Lei, Johan ^a   Luijsterburg, Pim A J ^a   Bierma Zeinstra, Sita M A ^b  

^a Department of General Practice ^*

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

Anti inflammatory agents; General practice; Non steroidal; Over the counter drugs; Primary care

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; NON PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG DOSE REGIMEN; DRUG USE; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MUSCULOSKELETAL DISEASE; PAIN; PEPTIC ULCER; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; RANDOM SAMPLE; RISK FACTOR; TREATMENT DURATION; CHEMICALLY INDUCED; GASTROINTESTINAL DISEASES; MIDDLE AGED; NETHERLANDS; RISK ASSESSMENT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NONPRESCRIPTION DRUGS; RISK ASSESSMENT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84898751453     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp14X677815     Document Type: Article

References (25)

1. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115(10): 787-796.
2. Hernandez-Diaz S, Rodriguez LA. Association between non-steroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160(14): 2093-2099.
3. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 2011; 8(9): e1001098.
4. Varas-Lorenzo C, Riera-Guardia N, Calingaert B, et al. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf 2011; 20(12): 1225-1236.
5. Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342: c7086.
6. Huerta C, Castellsague J, Varas-Lorenzo C, et al. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 2005; 45(3): 531-539.
7. The Dutch Institute for Health Care Improvement CBO. [Guideline for NSAID use and prevention of gastric damage]. Utrecht: The Dutch Institute for Health Care Improvement CBO, 2003. [In Dutch]
8. Lanza FL, Chan FK, Quigley EM; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009; 104(3): 728-738.
9. Chan FK, Abraham NS, Scheiman JM, et al. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Non-steroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol 2008; 103(11): 2908-2918.
10. Hoes AW, Walma EP, Rutten FH, et al. [Multidisciplinary guideline on heart failure]. Utrecht: The Dutch College of General Practice, the Dutch Society for Cardiology and the Dutch College of Internal Medicine, 2010. [In Dutch].
11. De Grauw WJC, Kaasjager HAH, Bilo HJG, et al. [National Transmural Consensus Chronic Renal Insufficiency]. Huisarts Wet 2009; 52(12): 586-697. [In Dutch].
12. Warlé-Van Herwaarden MF, Kramers C, Sturkenboom MC, et al. Targeting outpatient drug safety: Recommendations of the Dutch Harm-Wrestling Task Force. Drug Saf 2012; 35(3): 245-259.
13. Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int 2012; 32(6): 1491-1502.
14. French DP, James DH. Reasons for the use of mild analgesics among English students. Pharm World Sci 2008; 30(1): 79-85.
15. Moore N, Van Ganse E, Le Parc JM, et al. The PAIN Study: Paracetamol, Aspirin and Ibuprofen New Tolerability Study. A large scale randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Invest 1999; 18(2): 89-98.
16. Stosic R, Dunagan F, Palmer H, et al. Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use. Int J Pharm Pract 2011; 19(4): 236-245.
17. Central Bureau of Statistics. [Population; key statistics]. 2012. [In Dutch]. http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA= 37296ned&D1=a&D2=0,10,20,30,40,50,(l-1)-l&HD=130215-1329&HDR= G1&STB=T (accessed 25 Feb 2014).
18. Lamberts H, Wood M, Hofmans-Okkens IM. International primary care classifications: the effect of fifteen years of evolution. Fam Pract 1992; 9(3): 330-339.
19. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2014. Oslo, 2013. http://www.whocc.no/ filearchive/publications/2014-guidelines.pdf (accessed 4 March 2014).
20. van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in the Netherlands. Ann Intern Med 1993; 119(10): 1036-1041.
21. Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999; 38(4-5): 339-344.
22. Roumie CL, Griffin MR. Over-the-counter analgesics in older adults: a call for improved labeling and consumer education. Drugs Aging 2004; 21(8): 485-498.
23. Jeucken YM, van Minnen YPM, van der Werf GTh. [Use of over-the-counter NSAIDs by patients with contra-indications]. Huisarts Wet 2005; 8: 388-391. [In Dutch].
24. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on non-steroidal anti-inflammatory drugs. J Rheumatol 2005; 32(11): 2218-2224.
25. Medicines Evaluation Board. Motivation for classification system of legal status of supply for anti-inflammatories (NSAIDs) and acetylsalicylic acid, defined by the MEB on 2 July 2009. http://www.cbg-meb.nl/NR/rdonlyres/D97C7481- 5C4E-4488-851C-A3D3DE371DCB/0/UKMotiveringNSAIDs20090820.pdf (accessed 27 February 2014).